Protalix BioTherapeutics Aktie
WKN DE: A0ML0E / ISIN: US74365A1016
21.07.2025 13:32:15
|
Protalix BioTherapeutics Names Gilad Mamlok CFO
(RTTNews) - Protalix BioTherapeutics, Inc. (PLX), Monday announced the appointment of Gilad Mamlok as new Senior Vice President and Chief Financial Officer, effective August 24, 2025, succeeding Eyal Rubin.
After the end of Rubin's tenure, he will continue to be available to the company as necessary until October 2025.
Most recently, Mamlok served as the Chief Financial Officer of TytoCare Ltd.
In the pre-market hours, PLX is trading at $1.47, up 1.38 percent on the New York Stock Exchange American.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Protalix BioTherapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |